Moderna Says Studies Show Its Vaccine Is Effective Against The Delta Variant
Studies have found that Moderna’s COVID-19 vaccine is effective against several variants of concern, including the delta variant, the biotech company announced.
Moderna said Tuesday that recently completed studies have found the vaccine to have a neutralizing effect against all COVID-19 variants tested, including the beta, delta, eta and kappa variants.
While still highly effective against the delta variant, the study showed the vaccine was less effective against it and certain other variants than against the original strain of the virus.
The antibody response against the delta variant was about two times weaker than against the ancestral strain of the virus.
The news echoes other findings that the Moderna and Pfizer vaccines are highly effective against the delta variant. A study published this month in Nature found that Pfizer’s vaccine was able to neutralize variants including delta, though at somewhat reduced strength.
“These new data are encouraging and reinforce our belief that the Moderna COVID-19 Vaccine should remain protective against newly detected variants,” Stéphane Bancel, Moderna’s chief executive officer, said in a statement. “These findings highlight the importance of continuing to vaccinate populations with an effective primary series vaccine.”
The company also said it is developing a booster candidate: a 50-50 mix of its currently authorized COVID-19 vaccine and another messenger RNA vaccine it has developed.